Target intelligence / Profile preview

Ubiquitin-specific protease pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

ENSG00000235778 refers to a ubiquitin-specific protease pseudogene, also known as the ubiquitin carboxyl-terminal hydrolase 17-like pseudogene (LOC402329)[3]. Pseudogenes are genomic sequences related to protein-coding genes but are non-functional due to mutations or genetic rearrangements. Unlike their functional protein-coding relatives—such as the ubiquitin-specific protease (USP) family, which are involved in protein regulation via the ubiquitin-proteasome system and play key roles in processes like cell cycle regulation, apoptosis, and cancer—this pseudogene does not produce an active enzyme and does not participate in these pathways[3][2]. There are no known roles for this pseudogene in disease, no interacting drugs, and no mechanism of action or safety concerns associated with it. Its primary distinction is that, while it shares sequence similarity with functional USP genes, it remains non-functional and is not considered a therapeutic target.

Other names
ubiquitin carboxyl-terminal hydrolase 17-like pseudogeneLOC402329
02

Mechanism of action

None (not druggable, no mechanism of action)

03

Biological functions

None (does not produce a functional protein, no direct biological functions assigned)
04

Disease associations

None (no evidence for direct roles in disease due to its pseudogene status)
05

Safety considerations

None reported (not targeted pharmacologically, not a functional gene)
06

Interacting drugs

None (no available drugs interact with this pseudogene)
07

Biomarkers

None (not used as a biomarker, nor for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on Ubiquitin-specific protease pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-specific protease pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call